In the BioHarmony Drug Report Database
Dexedrine (dextroamphetamine) is a small molecule pharmaceutical. Dextroamphetamine was first approved as Dexedrine on 1982-01-01. It is used to treat attention deficit disorder with hyperactivity and narcolepsy in the USA. The pharmaceutical is active against sodium-dependent dopamine transporter and sodium-dependent noradrenaline transporter. In addition, it is known to target trace amine-associated receptor 1 and dopamine transporter.
Image (chem structure or protein)